Document is current

Article History

Accepted: 19 September 2023

First Online: 11 October 2023

Declarations

:

: The current work was not supported through any external funding.

: PEV received grants through institution contracts from F2G and Gilead Sciences, received honoraria for lectures paid to his institution from F2G, Gilead Sciences, and Pfizer, and participated on a Data Safety Monitoring Board or Advisory Board for F2G with payment through his institution. RJB has served as a consultant to Astellas Pharma, Inc., F2G, Amplyx, Gilead Sciences, Merck Sharp & Dohme Corp., Mundipharma, and Pfizer, Inc., and received unrestricted research grants from Astellas Pharma, Inc., Gilead Sciences, Merck Sharp & Dohme Corp., and Pfizer, Inc. All contracts and payments were through his institution. The other authors have no conflict of interest for the current work.

: The current analysis was performed in accordance with the ethical standards of the institutional research committee and the Declaration of Helsinki. Ethical approval has been granted for all studies from which data were included in the current analysis.

: Informed consent was obtained from all individual participants or their legal representatives.

: The datasets analysed for the current paper are available from the corresponding author on reasonable request and following legal approval.

: AJ performed the analysis; AJ interpreted the results with PV, RB, and RtH; AJ drafted the manuscript with RB and RtH; all authors critically reviewed the manuscript and approved the final version.